According to a recently published report by Brisk Insights, the Global Human Chorionic Gonadotropin Market is expected to grow at the CAGR of 6.1% during 2017-2025. The global human chorionic gonadotropin market is segmented on the basis of therapeutic area, technology and geography. The report on global human chorionic gonadotropin market (by therapeutic area, technology and geography) provides a detailed overview and predictive analysis of the market.

Full report available on Human Chorionic Gonadotropin Market: Global Industry Size, Growth, Share and Forecast to 2025 report at

Market Insights

Increasing prevalence of infertility which requires the use of human chorionic gonadotropin for its treatment and the demand for hormonal drug therapy are the key trends which are witnessed in the human chorionic gonadotropin market. In base year 2016, female infertility treatment held the largest market share in the therapeutic area segment due to factors such as growing incidence of infertility in women, contributed by increased maternity age and lifestyle effects. However, in the base year 2016, the technology market is segmented into (natural source extraction and recombinant DNA technology), Equal safety and efficacy of recombinant HCG in comparison to natural source HCG are the key driving factors that lead to higher demand for recombinant HCG in the global market. The human chorionic gonadotropin market is currently dominated by North America due to increasing prevalence of infertility, rising demand for hormonal drug therapy due to its safety and efficacy in comparison to synthetic drugs, supportive reimbursement policies and advanced healthcare infrastructure.

Browse here for all category Reports :

Scope of the report

1. Global Human Chorionic Gonadotropin Market, by therapeutic area, 2015–2025 ($ Million)

1.1. Female infertility treatment
1.2. Oligospermia treatment
1.3. Cryptorchidism treatment
1.4. Others

2. Global Human Chorionic Gonadotropin Market, by technology, 2015–2025 ($ Million)

2.1. Natural source extraction
2.2. Recombinant DNA technology

3. Global Human Chorionic Gonadotropin Market, by Geography, 2015-2025 ($ Million)

3.1. North America
3.1.1. U.S.
3.1.2. Canada
3.2. Europe
3.2.1. U.K.
3.2.2. Germany
3.2.3. Rest of Europe
3.3. Asia Pacific
3.3.1. Japan
3.3.2. China
3.3.3. Rest of Asia Pacific
3.4. Latin America
3.4.1. Mexico
3.4.2. Brazil
3.4.3. Rest of Latin America
3.5. Middle East and Africa
3.5.1. GCC
3.5.2. Rest of Middle East and Africa

Download Free Request Sample :

About Us :

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Contact Us :

Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
United Kingdom
Phone : +448081890034 (UK)
Email :
Website :